These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 3639088

  • 1. Hageman factor, high molecular weight kininogen, and prekallikrein in chronic liver disease.
    Cordova C, Violi F, Alessandri C, Ferro D, Saliola M, Balsano F.
    J Clin Pathol; 1986 Sep; 39(9):1003-5. PubMed ID: 3639088
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
    España F, Ratnoff OD.
    J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
    [Abstract] [Full Text] [Related]

  • 4. Interactions among Hageman factor, plasma prekallikrein, high molecular weight kininogen, and plasma thromboplastin antecedent.
    Ratnoff OD, Saito H.
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):958-61. PubMed ID: 284420
    [Abstract] [Full Text] [Related]

  • 5. Prekallikrein, HMW-kininogen and factor XII in various disease states.
    Deutsch E, Dragosics B, Kopsa H, Mannhalter C, Rainer H.
    Thromb Res; 1983 Jul 15; 31(2):351-64. PubMed ID: 6356459
    [Abstract] [Full Text] [Related]

  • 6. Hyperprolactinemia and reduction in plasma titers of Hageman factor, prekallikrein, and high molecular weight kininogen in patients with acute myocardial infarction.
    La Follette L, Gordon EM, Mazur CA, Ratnoff OD, Yamashita TS.
    J Lab Clin Med; 1987 Sep 15; 110(3):318-21. PubMed ID: 3649393
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prekallikrein behaviour in chronic active hepatitis and in cirrhotic patients.
    Cordova C, Musca A, Violi F, Alessandri C, Ferro D, Piromalli A, Balsano F.
    Haemostasis; 1984 Sep 15; 14(2):218-22. PubMed ID: 6564063
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Reduction of contact factors in sickle cell disease.
    Gordon EM, Klein BL, Berman BW, Strandjord SE, Simon JE, Coccia PF.
    J Pediatr; 1985 Mar 15; 106(3):427-30. PubMed ID: 3844465
    [Abstract] [Full Text] [Related]

  • 16. Dextran-induced anaphylactoid reaction in man: altered reactivity of high molecular weight kininogen.
    Briseid G, Briseid K.
    Acta Pharmacol Toxicol (Copenh); 1980 Aug 15; 47(2):119-26. PubMed ID: 6159774
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Surface activation of factor XII (Hageman factor)--critical role of high molecular weight kininogen and another potentiator).
    Chan JY, Burrowes CE, Movat HZ.
    Agents Actions; 1978 Jan 15; 8(1-2):65-72. PubMed ID: 636957
    [Abstract] [Full Text] [Related]

  • 19. The mechanism by which the light chain of cleaved HMW-kininogen augments the activation of prekallikrein, factor XI and Hageman factor.
    Silverberg M, Nicoll JE, Kaplan AP.
    Thromb Res; 1980 Oct 15; 20(2):173-89. PubMed ID: 6908319
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.